KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Evolent Health (EVH) Short-term Investments (2016 - 2025)

Historic Short-term Investments for Evolent Health (EVH) over the last 11 years, with Q3 2025 value amounting to $23.7 million.

  • Evolent Health's Short-term Investments rose 4494.89% to $23.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $23.7 million, marking a year-over-year increase of 4494.89%. This contributed to the annual value of $59.3 million for FY2024, which is 33067.26% up from last year.
  • Per Evolent Health's latest filing, its Short-term Investments stood at $23.7 million for Q3 2025, which was up 4494.89% from $24.4 million recorded in Q2 2025.
  • Evolent Health's Short-term Investments' 5-year high stood at $75.7 million during Q4 2021, with a 5-year trough of $13.8 million in Q4 2023.
  • Moreover, its 5-year median value for Short-term Investments was $23.7 million (2025), whereas its average is $33.4 million.
  • Per our database at Business Quant, Evolent Health's Short-term Investments skyrocketed by 42654.1% in 2021 and then tumbled by 8085.22% in 2022.
  • Over the past 5 years, Evolent Health's Short-term Investments (Quarter) stood at $75.7 million in 2021, then plummeted by 80.85% to $14.5 million in 2022, then dropped by 5.0% to $13.8 million in 2023, then skyrocketed by 330.67% to $59.3 million in 2024, then plummeted by 60.05% to $23.7 million in 2025.
  • Its last three reported values are $23.7 million in Q3 2025, $24.4 million for Q2 2025, and $16.2 million during Q1 2025.